CN103830388A - Traditional Chinese medicine for treating chronic hepatitis B - Google Patents
Traditional Chinese medicine for treating chronic hepatitis B Download PDFInfo
- Publication number
- CN103830388A CN103830388A CN201210491269.5A CN201210491269A CN103830388A CN 103830388 A CN103830388 A CN 103830388A CN 201210491269 A CN201210491269 A CN 201210491269A CN 103830388 A CN103830388 A CN 103830388A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- chronic hepatitis
- treating chronic
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine, particularly a traditional Chinese medicine for treating chronic hepatitis B. The traditional Chinese medicine is characterized by comprising the following components in parts by weight: 20-30g of Radix Scutellariae, 20-30g of Salvia miltiorrhiza, 5-15g of dried orange peel and 10-20g of kuh-seng. The traditional Chinese medicine has the advantages of medicine compatibility and complementarity, has the effects of clearing away heat, promoting blood circulation to remove blood stasis, and softening hardness to dissipate stagnation; due to the synergistic effect of pharmaceutical effect, the traditional Chinese medicine can be used for treating both principal and secondary aspect of disease, and has no side effect; the traditional Chinese medicine is prepared according to the differentiation theory of the traditional Chinese medicine, is simple in the formula, low in the preparation cost because the materials are easily obtained, good in the curative effect and free from any toxic and side effect, and can be used for effectively treating chronic hepatitis B.
Description
Affiliated technical field
The invention belongs to a kind of Chinese medicine, specifically a kind of Chinese medicine for the treatment of chronic hepatitis B.
Background technology
Chronic hepatitis B is that more than hepatitis b virus infection half a year virus is not thoroughly removed, and in body, hepatitis B virus is hidden or starts an inflammation of the liver morbidity.Chronic hepatitis B can have clear and definite acute hepatitis b to develop; Before half a year, had acute icteric or anicteric hepatitis outbreak medical history, treatment or spontaneous recovery are not thorough, and sow seeds of future trouble and hide, after half a year, or for many years, morbidity again.Also because infant has infected hepatitis B virus period, at that time because immunologic function is still unsound and perfect, can not be by virus sweep, virus lays dormant, in liver, after the silence of long-term immune tolerance, has approximately arrived the between twenty and fifty phase, just starts morbidity.Treatment chronic hepatitis B is generally that current Western medicine is in the majority at present, and western medicine result is fast but side effect is very big, can cause injury in various degree to stomach, liver.
Mostly use now the treatment of doctor trained in Western medicine method, can not remove root, easily repeatedly, treatment by Chinese herbs chronic hepatitis B is compared with the advantage of doctor trained in Western medicine maximum, effects a radical cure from pathology.Therefore spy of the present invention has further preferably adopted a kind of Chinese medicine for the treatment of chronic hepatitis B.
Summary of the invention
The present invention's object is exactly the technical deficiency for existing treatment chronic hepatitis B, a kind of Chinese medicine for the treatment of chronic hepatitis B that provides intelligence, and prescription is simple, has no side effect, and can effectively treat chronic hepatitis B.
The present invention is by the following technical solutions: the present invention is characterized in that it is made up of the component of following weight portion: Radix Scutellariae 20-30 gram, Radix Salviae Miltiorrhizae 20-30 gram, Pericarpium Citri Reticulatae 5-15 gram, Radix Sophorae Flavescentis 10-20 gram.
Further technical scheme of the present invention is: a kind of Chinese medicine for the treatment of chronic hepatitis B, it is characterized in that, and the crude drug of making effective ingredient by following weight is: 25 grams of Radix Scutellariaes, 25 grams of Radix Salviae Miltiorrhizaes, 10 grams of Pericarpium Citri Reticulataes, 15 grams of Radix Sophorae Flavescentiss.
Usage: one day potion, be decocted in water for oral dose, within 30 days, be a course for the treatment of, 3-4 month total course for the treatment of.
All medicine compatibilities of the present invention, bring out the best in each other, and have that control should heat clearing away, blood circulation promoting and blood stasis dispelling, and the effects such as hard masses softening and resolving, the synergism of drug effect, can treating both the principal and secondary aspects of a disease, good effect, instant effect.
The specific embodiment
A Chinese medicine for the treatment of chronic hepatitis B, is characterized in that, the crude drug of making effective ingredient by following weight is: 25 grams of Radix Scutellariaes, 25 grams of Radix Salviae Miltiorrhizaes, 10 grams of Pericarpium Citri Reticulataes, 15 grams of Radix Sophorae Flavescentiss.
Apply clinical trial of the present invention:
1. case-data
Patient's case 60 examples.
2. Therapeutic Method
One day potion, is decocted in water for oral dose, and within 30 days, is a course for the treatment of, and be 3-4 month total course for the treatment of.
3. curative effect determinate standard
Effective: chronic hepatitis B remission.
Cure: physical recovery is to normal.
4. result
Patient uses 3-4 of the present invention month, and effective 60 examples are cured 48 examples, cure rate 80%, effective percentage 100%.
Claims (2)
1. treat a Chinese medicine for chronic hepatitis B, it is characterized in that it is made up of the component of following weight portion: Radix Scutellariae 20-30 gram, Radix Salviae Miltiorrhizae 20-30 gram, Pericarpium Citri Reticulatae 5-15 gram, Radix Sophorae Flavescentis 10-20 gram.
2. a kind of Chinese medicine for the treatment of chronic hepatitis B according to claim 1, is characterized in that it is made up of the component of following weight portion: 25 grams of Radix Scutellariaes, 25 grams of Radix Salviae Miltiorrhizaes, 10 grams of Pericarpium Citri Reticulataes, 15 grams of Radix Sophorae Flavescentiss.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210491269.5A CN103830388A (en) | 2012-11-28 | 2012-11-28 | Traditional Chinese medicine for treating chronic hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210491269.5A CN103830388A (en) | 2012-11-28 | 2012-11-28 | Traditional Chinese medicine for treating chronic hepatitis B |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103830388A true CN103830388A (en) | 2014-06-04 |
Family
ID=50794490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210491269.5A Pending CN103830388A (en) | 2012-11-28 | 2012-11-28 | Traditional Chinese medicine for treating chronic hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103830388A (en) |
-
2012
- 2012-11-28 CN CN201210491269.5A patent/CN103830388A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104027775A (en) | Traditional Chinese medicine for treating thromboangiitis obliterans | |
CN104027394A (en) | Traditional Chinese medicine preparation for treating fracture and traumatic injury | |
CN102327493A (en) | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases | |
CN103830388A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
CN103845483A (en) | Traditional Chinese medicine for treating hepatitis B | |
CN103830606A (en) | Traditional Chinese medicine for treating synovitis | |
CN103893586A (en) | Traditional Chinese medicine for treating acute tonsillitis | |
CN104189227A (en) | Traditional Chinese medicine used for treating rosacea | |
CN104027555A (en) | Traditional Chinese medicine for treating acute mastitis | |
CN104258326A (en) | Traditional Chinese medicine used for treating scapulohumeral periarthritis | |
CN104042762A (en) | Traditional Chinese medicine composition for treating mumps | |
CN105770548A (en) | Externally-used traditional Chinese medicine for treating skin eczema | |
CN103845654A (en) | Traditional Chinese medicine for treating exudative otitis media | |
CN104258107A (en) | Traditional Chinese medicine for treating postartum convulsion | |
CN103893425A (en) | Traditional Chinese medicine for treating infantile cough | |
CN105878434A (en) | Traditional Chinese medicine compound for treating cervical spondylosis | |
CN104383368A (en) | Traditional Chinese medicine composition for treating bronchiectasia | |
CN102342998A (en) | Traditional Chinese drug composition for treating chronic enteritis | |
CN103845645A (en) | Traditional Chinese medicine for treating vicarious menstruation | |
CN103845402A (en) | Traditional Chinese medicine for treating acute mastitis | |
CN103860924A (en) | Traditional Chinese medicine for treating epistaxis | |
CN101991686A (en) | Oral Chinese medicine formula for treating eczema | |
CN103933190A (en) | Traditional Chinese medicine washing lotion for treating systematic skin pruritus | |
CN104042785A (en) | Traditional Chinese medicine composition for treating epidemic mumps | |
CN102247543A (en) | Hepatitis B virus killing medicine for treating hepatitis B with positive HBsAg, HBeAg and HBcAb, hepatitis B with positive HBsAg, HBeAb and HBcAb and various liver diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140604 |